U.S. Insurance Stock News

NYSE:FBP
NYSE:FBPBanks

How Investors Are Reacting To First BanCorp (FBP) Rising Labor-Driven Operational And Credit Pressures

Recently, First BanCorp reported that widespread labor shortages across Puerto Rico, the U.S., the Virgin Islands, and other markets are disrupting many commercial clients’ operations, tightening supply chains, pressuring cash flows, and increasing the risk that some borrowers may struggle to meet loan obligations. The same labor constraints are raising First BanCorp’s own wage costs and creating staffing gaps, which could pressure service quality and introduce additional operational and...
NYSEAM:BMNR
NYSEAM:BMNRSoftware

Bitmine Expands Ethereum Treasury As Valuation And Momentum Send Mixed Signals

Bitmine Immersion Technologies acquired 50,928 ETH, taking its total Ethereum holdings to more than 4.4 million. The move reinforces Bitmine's role as a large Ethereum treasury and expands its exposure to ETH staking. The company, which trades as NYSEAM:BMNR, last closed at $19.57. Bitmine Immersion Technologies (NYSEAM:BMNR) is leaning further into its Ethereum-focused model with this large purchase of ETH. The company already positions itself as an Ethereum treasury play, and this move...
NYSE:JOE
NYSE:JOEReal Estate

Is It Too Late To Consider St. Joe (JOE) After A Strong Share Price Run?

If you are wondering whether St. Joe's current share price still offers value, it helps to step back and look at what the numbers are really saying about the business. The stock last closed at US$72.79, with returns of 4.0% over 7 days, 10.0% over 30 days, 21.7% year to date, 56.8% over 1 year, 82.4% over 3 years and 56.4% over 5 years, which will naturally raise questions about how the current price lines up with underlying value. Investors have been watching St. Joe as it continues to...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Assessing Affirm Holdings (AFRM) Valuation After Expanded Stripe Partnership In AI Driven Commerce

Affirm Holdings (AFRM) is back in focus after announcing an expanded partnership with Stripe that will add its pay over time financing to Shared Payment Tokens used in AI driven shopping and checkout experiences. See our latest analysis for Affirm Holdings. Despite the Stripe and AI commerce news putting Affirm back in the headlines, the share price at US$47.83 reflects a 30 day share price return decline of 20.68% and a 90 day share price return decline of 31.32%, while the 3 year total...
NYSE:CNX
NYSE:CNXOil and Gas

Why CNX Resources (CNX) Is Up 11.6% After Refinancing 2029 Notes With New 2034 Issue – And What's Next

In late February 2026, CNX Resources completed a private placement of US$500,000,000 in 5.875% senior notes due 2034, guaranteed by its restricted subsidiaries and sold to qualified institutional and non-U.S. investors under Rule 144A and Regulation S. CNX is using the proceeds to retire its 6.000% senior notes due 2029 through a tender offer and redemption, reshaping its debt profile and interest obligations. We’ll now examine how refinancing 6.000% 2029 notes with 5.875% 2034 notes could...
NYSE:EVR
NYSE:EVRCapital Markets

A Look At Evercore’s (EVR) Valuation As New Leadership Targets Healthcare And Asia Growth

Leadership additions reshape Evercore’s sector and regional focus Evercore (EVR) has been in focus after appointing Ben Carpenter to strengthen its healthcare and biopharma investment banking practice and Ben Hart to lead Asia Private Capital Advisory, signaling a push in sector and regional coverage. See our latest analysis for Evercore. Despite the recent appointments and other corporate updates, Evercore’s share price has eased back, with a 30 day share price return of a 12.88% decline,...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

Is It Too Late To Consider BOK Financial (BOKF) After Strong Multi‑Year Share Gains?

Wondering if BOK Financial is offering real value at its current share price, or if most of the upside is already priced in? This article walks through the numbers so you can judge how the stock stacks up. The share price last closed at US$128.46, with returns of a 0.6% decline over 7 days, a 1.1% decline over 30 days, 8.2% year to date, 25.3% over 1 year and 55.0% over 5 years, which gives plenty of history to assess how the market has priced the business. Recent coverage around BOK...
NYSE:ADT
NYSE:ADTConsumer Services

Is ADT (ADT) Offering A Fresh Opportunity After Recent Share Price Weakness

If you are wondering whether ADT is attractively priced today or if the security specialist is a potential value trap in your portfolio, this article is for you. ADT shares last closed at US$6.85, with returns of a 13.1% decline over 7 days, a 14.4% decline over 30 days, a 14.5% decline year to date and a 7.3% decline over 1 year, while the 5 year return sits at 0.9%. These moves have kept ADT on many investors' watchlists, especially among those focused on how sentiment about home and...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

Rambus (RMBS) Faces Supply Chain Probe While Courting AI Memory Role – Is Resilience Mispriced?

In late February 2026, The Schall Law Firm began investigating Rambus Inc. for potential securities law violations after the company disclosed a supply chain disruption affecting its first-quarter 2026 operations. This combination of legal scrutiny and operational strain raises fresh questions about Rambus’s disclosure practices and operational resilience at a time when it is repositioning itself as a core supplier to AI memory infrastructure. We’ll now examine how the investigation into...
NYSE:LMT
NYSE:LMTAerospace & Defense

Is It Too Late To Consider Lockheed Martin (LMT) After A 52.9% One-Year Surge?

If you have ever looked at Lockheed Martin and wondered whether the current share price really matches its underlying value, you are not alone. The stock most recently closed at US$667.82, with returns of 0.5% over 7 days, 5.3% over 30 days, 34.4% year to date, 52.9% over 1 year, 51.2% over 3 years and 126.5% over 5 years. Recent headlines have continued to focus on Lockheed Martin as a key global defense contractor, with investors paying close attention to contract activity, geopolitical...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Assessing Constellium (CSTM) Valuation After Profit Return Buybacks And Sustainability Progress

Constellium (CSTM) is back in the spotlight after reporting fourth quarter and full year 2025 results, with sales of US$2,201 million in the quarter and a shift from a net loss to net income. See our latest analysis for Constellium. The strong quarterly and full year results, together with the recently completed share buyback and sustainability update, come after a powerful run in the shares, with a 30.65% year to date share price return and a very large 153.98% total shareholder return over...
NYSE:YSG
NYSE:YSGPersonal Products

Yatsen Holding (NYSE:YSG) Returns To Quarterly Profit, Testing Bearish Profitability Narratives

Yatsen Holding (NYSE:YSG) has capped FY 2025 with fourth quarter revenue of C¥1.4b and basic EPS of C¥0.09, a clear contrast to the loss profile seen earlier in the year. The company has seen quarterly revenue move from C¥833.5m in Q1 2025 to C¥1.4b in Q4, while basic EPS has shifted from a loss of C¥0.06 in Q1 and C¥0.19 in Q2 to a profit in Q4, against a trailing twelve month EPS of a C¥1.35 loss and net income loss of C¥80.9m on C¥4.3b of revenue. That mix of stronger recent EPS and still...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Should Dupixent’s New Allergic Fungal Rhinosinusitis Approval Shift How Regeneron (REGN) Investors View Its Immunology Story?

In late February 2026, Regeneron Pharmaceuticals and Sanofi reported U.S. FDA approval of Dupixent for allergic fungal rhinosinusitis in patients aged 6 and older with prior sino-nasal surgery, while securing a positive EU opinion for pediatric chronic spontaneous urticaria and Priority Review for garetosmab in fibrodysplasia ossificans progressiva. These updates underscore how Regeneron is broadening Dupixent’s reach across difficult-to-treat type 2 inflammatory diseases while advancing an...
NYSE:AON
NYSE:AONInsurance

Is Aon (AON) Offering Value After Recent Share Price Volatility And Risk Sector Focus

If you are trying to work out whether Aon’s current share price gives you value or not, this article will walk through what the numbers actually say rather than just the headline moves. Aon recently closed at US$339.07, with returns of 6.2% over the past week, a 3.0% decline over the last month, a 1.5% decline year to date, and longer term returns of 15.2% over 3 years and 52.4% over 5 years, alongside a 15.5% decline over the past year. Recent news around Aon has largely focused on its role...
NasdaqGS:IHRT
NasdaqGS:IHRTMedia

IHRT Q4 Loss Narrows To US$0.27 EPS As Turnaround Narrative Faces Ongoing Skepticism

iHeartMedia (IHRT) closed out Q4 FY 2025 with revenue of US$1.1 billion and a basic EPS loss of US$0.27, as net income excluding extra items came in at a loss of US$41.9 million. Trailing 12 month figures showed revenue of US$3.9 billion and a basic EPS loss of US$3.05 tied to a net loss of US$472.9 million. Over recent quarters, the company has seen revenue range from US$807.1 million in Q1 2025 to US$1.1 billion in Q4 2025, alongside quarterly EPS losses between US$0.27 and US$1.84. This...
NYSE:EPD
NYSE:EPDOil and Gas

How Enterprise’s Conference Spotlight On Midstream Scale And Income Profile At EPD Has Changed Its Investment Story

In late February and early March 2026, Enterprise Products Partners L.P. participated in multiple investor conferences, including THRIVE Energy in Houston and Jefferies’ Power, Utilities & Clean Energy event in New York, highlighting its extensive midstream energy infrastructure and recent project additions. These appearances gave management a platform to underscore Enterprise’s long record of distribution growth, A- credit rating, and expanding NGL and export capabilities, reinforcing its...
NYSE:VRT
NYSE:VRTElectrical

Is It Too Late To Consider Vertiv (VRT) After Its Surging Share Price?

If you are wondering whether Vertiv Holdings Co at around US$244 per share still offers value after its huge run, you are not alone. The stock has seen a 31.3% return over the last 30 days, 39.2% year to date and 183.3% over the past year, although the last 7 days included a 3.4% decline. Recent coverage has focused on Vertiv's role in data center and power infrastructure, which has kept attention on the stock and provided context for its very strong multi year returns, with the 3 year...
NasdaqGS:UMBF
NasdaqGS:UMBFBanks

A Look At UMB Financial (UMBF) Valuation As Inflation And Credit Risk Concerns Pressure Bank Sentiment

UMB Financial (UMBF) moved into focus after its shares fell 7% as hotter-than-expected inflation data and renewed worries about credit risk pressured bank stocks that are closely tied to economic conditions. See our latest analysis for UMB Financial. That sharp one day drop sits within a weaker recent patch, with a 30 day share price return of 7.39% decline and a 7 day share price return of 1.56% decline. However, the year to date share price return of 1.08% and 1 year total shareholder...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

Keurig Dr Pepper Reshapes Coffee And Beverages With Split And JDE Peet’s Deal

Keurig Dr Pepper (NasdaqGS:KDP) plans to separate into two pure play companies, creating independently focused beverage and coffee systems businesses. The company announced an agreement to acquire JDE Peet’s, expanding its coffee platform and geographic reach. Keurig Dr Pepper introduced the Keurig Coffee Collective, its first branded premium coffee line under the Keurig name. These moves coincide with changes in senior board leadership, signaling a new phase for the company. Keurig Dr...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

A Look At Definium Therapeutics (DFTX) Valuation As Wider Full Year Loss Refocuses Investor Expectations

What the wider loss at Definium Therapeutics means for shareholders Definium Therapeutics (DFTX) reported a full year 2025 net loss of US$183.79 million, compared with US$108.68 million a year earlier, with basic loss per share from continuing operations at US$2.06 versus US$1.54. For you as a shareholder or potential buyer, this wider loss focuses attention on how the company funds its late stage pipeline, particularly as DT120 advances in phase 3 and DT402 progresses through phase 2a...
NYSE:CE
NYSE:CEChemicals

Assessing Celanese (CE) Valuation As Debt Cuts And Michigan Tech Expansion Target A Demand Recovery

Celanese (CE) just expanded its Michigan Technology Center, connecting this larger research and development hub to its Engineered Materials 2026 plan, while simultaneously working to slim debt and prepare for a potential demand recovery. See our latest analysis for Celanese. The recent expansion of the Michigan Technology Center comes as Celanese’s share price shows stronger short term momentum, with a 15.48% 1 month share price return and 22.66% 3 month share price return. In contrast, the 5...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI Leadership Shift And Forging Expansion Reshape Aerospace Supplier Role

ATI (NYSE:ATI) has appointed CEO Kimberly Fields as chair of the board, consolidating leadership roles at the company. Under Fields' leadership, ATI is moving to double forging output to support Pratt & Whitney and help address aerospace production constraints. ATI, traded as NYSE:ATI, supplies high performance materials and components to aerospace and other industrial customers. With aircraft manufacturers and engine makers working through production challenges, the reliability of key...
NYSE:ALEX
NYSE:ALEXREITs

Assessing Alexander & Baldwin (ALEX) Valuation After Recent Share Price Strength

Assessing Alexander & Baldwin after recent performance shifts Alexander & Baldwin (ALEX) has drawn fresh attention as investors reassess its Hawai‘i focused commercial real estate portfolio in light of recent share performance and current earnings and revenue trends. See our latest analysis for Alexander & Baldwin. At a share price of US$20.83, Alexander & Baldwin has seen a 90 day share price return of 35.17%, while its 1 year total shareholder return of 24.02% suggests that momentum has...
NYSE:PNC
NYSE:PNCBanks

PNC Branch Overhaul Tests US$2b Expansion Against Valuation Opportunity

PNC Financial Services Group (NYSE:PNC) plans to invest about US$2b to open more than 300 new branches across the United States by 2030. The bank is pairing this build out with selective closures of lower activity locations as part of a broader restructuring of its retail branch network. The approach includes growing in markets such as Charlotte, while reallocating resources and closing certain branches in areas such as Dayton, Ohio. For you as an investor, this move sits at the heart of...